Company intelligence / Profile preview

CMIC HOLDINGS Co., Ltd.

Ownership: Private
Employees: ~6354
Development stage: Commercial

Overview

CMIC is Japan’s first and largest CRO, providing end-to-end solutions including clinical development, manufacturing, regulatory consulting, site management, sales/marketing support, patient support programs, digital health platforms and more. The company enables global pharmaceutical and biotech companies to develop drugs faster and access the Japanese market efficiently. It also has significant CDMO capabilities for both small molecules and biologics.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small moleculeBiologicMonoclonal antibodyOligonucleotideCell therapyGene therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on CMIC HOLDINGS Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMIC HOLDINGS Co., Ltd..

Explore the full profile